Chief physician

PD Dr med. Lukas Altwegg

PD Dr med.

Priority areas

  • Percutaneous treatment of acute coronary syndrome
  • Percutaneous non-coronary interventions: especially percutaneous aortic valve implantation (TAVI)

Areas of research and interest

  • Acute coronary syndrome
  • Research into the mechanisms (including the role of inflammation)
  • Improvement of early diagnosis
  • Percutaneous treatment of aortic stenosis
  • Evaluation of new catheters and prostheses
  • Procedural safety (co-operation with Swiss Aviation Training)
  • Research into postoperative inflammatory reactions
  • Quality control of clin. Results (via national register)

Professional career

Curriculum vitae

2013

Habilitation University of Zurich

Since 2013

Head of Cardiology, Claraspital Basel

2009-2012

Senior Physician Cardiology, University Hospital Zurich

2009 - 2011

SNF-Clinical research candidate for SPUM (Special Programme University Medicine)

2006-2008

Fellowship in Interventional Cardiology, St Paul's Hospital, Vancouver

2004

Specialist title in cardiology

Memberships and commitments

List of memberships

Swiss Medical Association (FMH)

Swiss Society of Cardiology

Swiss Working Group for Interventional Cardiology and Acute Coronary Syndromes

Zurich Society of Cardiology

Steering Committee Swiss TAVI Registry

Pu­bli­ca­ti­ons

  • Riwanto M., Rohrer L., Roschitzki B., Besler C., Mocharla P., Mueller M., Perisa D., Heinrich K., Altwegg L., von Eckardstein A., Lüscher T.F., Landmesser U.: Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodelling. Circulation. 2013; 127(8): 891-904.
  • Ghadri J.R., Jaguszewski M., Sacron A., Srikantharupan S., Pfister P., Siddique A., Kaufmann P.A., Wyss C.A., Gaemperli O., Landmesser U., Altwegg L., Maier W., Corti R., Lüscher T.F., Templin C.: Current outcome of acute coronary syndromes: data from the Zurich-Acute Coronary Syndrome (Z-ACS) Registry. Cardiovascular Medicine. 2013; 16(4): 115-122.
  • Stähli B.E., Tasnady H., Lüscher T.F., Gebhard C., Mikulicic F., Erhart L., Bühler I., Landmesser U., Altwegg L., Wischnewsky M.B., Grünenfelder J., Falk V., Corti R., Maier W.: Early and late mortality in patients undergoing transcatheter aortic valve implantation: comparison of the novel EuroScore II with established risk scores. Cardiology. 2013; 126(1): 15-23.
  • Stähli B.E., Tasnadya H., Altwegg L., Bühler I., Grünenfelder J., Landmesser U., Tanner F.C., Wischnewsky M.B., Falk V., Lüscher T.F., Corti R., Maier W.: Outcomes after transcatheter aortic valve implantation: a single centre registry of 350 consecutive cases. Cardiovascular Medicine. 2013; 16(9): 235-242.
  • Nguyen-Kim T.D., Sahin A., Sündermann S.H., Winklehner A., Grünenfelder J., Emmert M.Y., Maier W., Altwegg L., Frauenfelder T., Falk V., Plass A.: Evaluation of calcium loss after transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2014; 18(1): 67-72.